SKA3 and triple-negative breast carcinoma: Thus, we explore the Asian-specific group further in the TCGA data, the results showed that SKA3 was overexpressed in ER-negative, PR-negative, triple-negative breast cancer patients and decreased status, which was roughly corresponding with our results (Figs. 6C–6F).